Reposted by Luis M
New paper out by an ISAR member lab
www.sciencedirect.com/science/arti...
Bemnifosbuvir and ruzavir are potent inhibitors of hepatitis C virus.
And act synergistically in vitro when combined.
sciencedirect.com
Bemnifosbuvir and ruzasvir in combination exhibit potent synergistic antiviral activity in vitro while maintaining a favorable nonclinical safety profile in vivo
Bemnifosbuvir (BEM), the orally available hemisulfate salt of the double prodrug of a guanosine nucleotide analog, is a potent, selective, and pan-gen…
